Columns - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Columns

Global correspondents report on industry trends and markets around the world. Plus: learn what companies are doing to improve global healthcare on the ground and to strengthen their corporate social responsibility (CSR) and sustainability.

Insights into trends and challenges facing contract service providers and users in the pharmaceutical and biopharmaceutical industries from outsourcing pros, Jim Miller, Eric Langer, and Gregg Brandyberry.

View Columns

Key government and regulatory developments affecting biotech and pharmaceutical manufacturers from Washington Editor Jill Wechsler.

View Columns

Coverage of packaging equipment, containers, systems, and materials from pharmaceutical packaging expert Hallie Forcino.

View Columns

Sponsored by:

The latest business and scientific developments in manufacturing active pharmaceutical ingredients, intermediates, and excipients.

View Columns

Contributors from PriceWaterhouseCoopers, Tufts, and PRTM address key policy, finance, and technical issues facing the biopharmaceutical manufacturing industry.

View Columns

From the Editor perspectives and PharmTech Talk by PharmTech editors, and guest editorials offer perspectives on the industry.

View Columns

Pharmaceutical industry members and associations, including PhRMA, BIO, and GPhA, share their views on the issues impacting pharmaceutical manufacturers and their suppliers.

View Columns

Professionals in the field describe and evaluate recent books about regulation, analytical techniques, formulation, drug delivery, and other topics.

View Columns

A weekly roundup of company mergers, deals, expansions, personnel news, and more.

View Columns

Exclusive insider observation and analysis from standard-setting and regulatory organizations, including USP, IPEC, ICH, PIC/S, and more. Plus, Susan J. Schniepp provides Insider Solutions for key compendial and QA/QC challenges.

View Columns

True-life cautionary tales from the secret files of "Control," a senior compliance officer at a US pharmaceutical manufacturer.

View Columns

Statistical Solutions

Statistician Lynn D. Torbeck evaluates and analyzes relevant statistical methods for the pharmaceutical industry.

View Columns

An update on the latest issues, regulations and trends affecting pharmaceutical manufacturers from industry expert Nathan Jessop.

View Columns


Past Columns

Faiz Kermani's Spotlight
Coming Down the Pike
See Also: Annual Survey Results

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Looking forward 10 years from now, what do you think will be the most significant change to drug development and manufacturing?
Fuller adoption of quality by design principles
Greater adoption of continuous manufacturing
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
The rise of biologic-based drugs in commercial product portfolios and pipelines
Greater adoption of the preferred provider model in outsourcing
Fuller adoption of quality by design principles
22%
Greater adoption of continuous manufacturing
7%
A stronger movement to personalized medicine and the use of diagnostics with traditional pharmaceuticals
35%
The rise of biologic-based drugs in commercial product portfolios and pipelines
30%
Greater adoption of the preferred provider model in outsourcing
7%
View Results
Jim MillerOutsourcing OutlookJim Miller Channeling Steve Jobs
Patricia Van ArnumIngredients InsiderPatricia Van ArnumSeeking Chemocatalytic and Biocatalytic Solutions
Nathan JessopIndustry InsiderNathan Jessop Taxing Times for French Pharma
Lynn D. TorbeckStatistical Solutions Lynn D. TorbeckRepresentative Sampling
FindPharma Custom Search
Click here